SIRT1

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA006295

Antibody CAB003855

Tissue

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Strong nuclear immunoreactivity, often accompanied with weak to moderate cytoplasmic staining, was observed in cervical and ovarian cancers and in embryonal carcinomas of testis. In squamous cell carcinomas, keratinized parts were strongly stained. Some endometrial cancers displayed additional membranous positivity. Most other tumors were weakly or moderately stained in cytoplasm or nuclei. Most malignant cells were negative or displayed weak nuclear immunoreactivity. Strong staining was observed in testicular cancers and in rare cases of head & neck-, lung- and liver cancers.

Validation

Uncertain: Two (or more) antibodies yielding partly similar staining patterns which are partly consistent with gene/protein characterization data or consistent with limited gene/protein characterization data
Uncertain: Two (or more) antibodies yielding partly similar staining patterns which are partly consistent with gene/protein characterization data or consistent with limited gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected